Blood-Based MRD Testing Identifies AML Patients at Risk of Relapse After Stem Cell Transplant

Researchers looked at AML variants in the blood of patients prior to their allogeneic hematopoietic cell transplant and correlated them with subsequent relapse or death.
Read the full article at: www.precisiononcologynews.com
Continue Reading »FDA OKs ReWalk’s exoskeleton tech for stairs and curbs
The ReWalk personal exoskeleton is the first to be cleared in the U.S. to help partially paralyzed users surmount stairs and curbs.
Read the full article at: www.fiercebiotech.com
Continue Reading »A Turning Point for Continuous Glucose Monitors
A local coverage determination for continuous glucose monitors set to go into effect in mid-April could significantly expand the market.
Read the full article at: www.mddionline.com
Continue Reading »Evonik, BellaSeno Team Up to Commercialize 3D-Printed Implants
The resorbable bone scaffolds are printed using polymers from Evonik’s Resomer portfolio.
Read the full article at: www.plasticstoday.com
Continue Reading »Comprehensive plan for phasing out the use of animals in experimentation
PETA scientists have just released a new edition of the groundbreaking Research Modernization Deal (RMD), the world’s first comprehensive plan for phasing out the use of animals in experimentation. The update is packed with new, cutting-edge information and reflects the latest scientific…
Read the full article at: www.news-medical.net
Continue Reading »Medtronic Product Catalysts to Watch for in 2023
These products are expected to be strong growth drivers for the industry’s largest player.
Read the full article at: www.mddionline.com
Continue Reading »Tinnitus treatment with the first neuromodulation device gets cleared by the FDA
When it comes to Neuromod Devices’ neurostimulation system to relieve tinnitus, the FDA is all ears.
Read the full article at: www.fiercebiotech.com
Continue Reading »FDA backs neurostim device for at-home depression treatment
According to a 2022 study, half of 410 participants saw their depressive symptoms reduced by at least 50% after using Sooma Medical’s device.
Read the full article at: www.fiercebiotech.com
Continue Reading »Investors Are Taking Notice of Organ Preservation Company Paragonix
The company’s organ preservation methods represent a significant improvement over traditional ice and cooler practices still used today.
Read the full article at: www.mddionline.com
Continue Reading »Robotic Bronchoscopy Trial Launches in Australia
The first-in-human trial will evaluate Noah Medical’s Galaxy System, an integrated solution for navigated robotic bronchoscopy.
Read the full article at: www.mddionline.com
Continue Reading »